THE INTERNATIONAL COMPARATIVE LEGAL GUIDE TO: PATENTS 2012
A PRACTICAL CROSS-BORDER INSIGHT INTO PATENTS LAW CHAPTER 17 – MEXICO by Alejandro Luna & César Ramos, Jr. READ THE FULL CHAPTER here (Adobe Acrobat Reader required to view this article). “This article appeared in the 2011 edition of The International Comparative Legal Guide to: Patents; published by Global Legal Group Ltd, London.”
Read More
Mexico gets ready to approve biocomparable drugs
BY ALEJANDRO LUNA PARTNER AND JUAN LUIS SERRANO MEXICO’S DRUG REGULATORS ARE PREPARING TO ISSUE NEW RULES ON BIOCOMPARABLE DRUGS. Mexico’s General Health Law was reformed on June 11 2009 in ways that will have an important impact on patent owners within the pharmaceutical and life sciences industries. The law was amended to include an article 222 bis,[...]
Read More
The reasons for valuation
BY GUSTAVO A. ALCOCER PARTNER AND CARLOS WOODWORTH MANAGING INTELLECTUAL PROPERTY, JUNE 2005 INTELLECTUAL PROPERTY VALUATION HAS NOVELTY VALUE AMONG IP PROFESSIONALS NOT USED TO THE MAINSTREAM IMPORTANCE OF INTANGIBLE ASSETS. We used to refer to IP valuation as a new trend with increasing importance in proportion to the increased relevance of IP when compared to tangible[...]
Read More
Pharmaceutical Advertising 2009
BY ALEJANDRO LUNA, PARTNER AND JUAN LUIS SERRANO CHAPTER 30, THE INTERNATIONAL COMPARATIVE LEGAL GUIDE TO: PHARMACEUTICAL ADVERTISING 2009 GENERAL – MEDICINAL PRODUCTS 1.1 WHAT LAWS AND CODES OF PRACTICE GOVERN THE ADVERTISING OF MEDICINAL PRODUCTS IN MEXICO? Advertising of medicinal products in Mexico is mainly governed by the General Health Law, and the Regulations of the General[...]
Read More
Mexican Linkage Gazette Ago. 2015 Erratum
LEER LA PUBLICACIÓN COMPLETA aquí (Se requiere Adobe Acrobat Reader).
Read More